The approval is based on findings from a phase 3 study which demonstrated the drug’s superiority over chemotherapy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback